Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Chembiochem : a European Journal of Chemical Biology
|
July 4, 2014
Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure
Bryan D Cox, Anthony R Prosser, Brooke M Katzman, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|
April 8, 2014
Student use of health literacy tools to improve patient understanding and medication adherence
Gloria R Grice, Amy Tiemeier, Peter Hurd, et al.
The American Journal of Medicine
|
April 1, 1979
Feedback-controlled dextrose infusion during surgical management of insulinomas
J H Karam, M Lorenzi, C W Young, et al.
Oncotarget
|
April 24, 2018
Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells
Ming-Bo Huang, Kyle E Giesler, Brooke M Katzman, et al.
The Journal of Organic Chemistry
|
July 13, 2013
Formal substitution of bromocyclopropanes with nitrogen nucleophiles
Joseph E Banning, Jacob Gentillon, Pavel G Ryabchuk, et al.
Archives of Environmental Contamination and Toxicology
|
September 27, 2025
Effects of the Aquatic Herbicide Diquat on Non-Target Aquatic Biota: A Mesocosm Study
R L Dalton, S A Robinson, A J Bartlett, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2015
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
Bryan D Cox, Anthony R Prosser, Yongnian Sun, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor
Brooke M Katzman, Bryan D Cox, Anthony R Prosser, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2014
Discovery of tetrahydroisoquinoline-based CXCR4 antagonists
Valarie M Truax, Huanyu Zhao, Brooke M Katzman, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
J D Doecke, F Hartnell, P Bampton, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Chembiochem : a European Journal of Chemical Biology
|
July 4, 2014
Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure
Bryan D Cox, Anthony R Prosser, Brooke M Katzman, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|
April 8, 2014
Student use of health literacy tools to improve patient understanding and medication adherence
Gloria R Grice, Amy Tiemeier, Peter Hurd, et al.
The American Journal of Medicine
|
April 1, 1979
Feedback-controlled dextrose infusion during surgical management of insulinomas
J H Karam, M Lorenzi, C W Young, et al.
Oncotarget
|
April 24, 2018
Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells
Ming-Bo Huang, Kyle E Giesler, Brooke M Katzman, et al.
The Journal of Organic Chemistry
|
July 13, 2013
Formal substitution of bromocyclopropanes with nitrogen nucleophiles
Joseph E Banning, Jacob Gentillon, Pavel G Ryabchuk, et al.
Archives of Environmental Contamination and Toxicology
|
September 27, 2025
Effects of the Aquatic Herbicide Diquat on Non-Target Aquatic Biota: A Mesocosm Study
R L Dalton, S A Robinson, A J Bartlett, et al.
ACS Medicinal Chemistry Letters
|
July 21, 2015
Pyrazolo-Piperidines Exhibit Dual Inhibition of CCR5/CXCR4 HIV Entry and Reverse Transcriptase
Bryan D Cox, Anthony R Prosser, Yongnian Sun, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Tetrahydroisoquinoline CXCR4 Antagonists Adopt a Hybrid Binding Mode within the Peptide Subpocket of the CXCR4 Receptor
Brooke M Katzman, Bryan D Cox, Anthony R Prosser, et al.
ACS Medicinal Chemistry Letters
|
June 18, 2014
Discovery of tetrahydroisoquinoline-based CXCR4 antagonists
Valarie M Truax, Huanyu Zhao, Brooke M Katzman, et al.
Alimentary Pharmacology & Therapeutics
|
December 21, 2016
Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study
J D Doecke, F Hartnell, P Bampton, et al.
Page
of 6